Proteinuria following a switch from calcineurin inhibitors to sirolimus

Emmanuel Letavernier1, Marie-Noëlle Pe'raldi, Antoine Pariente

  • 1Service de Transplantation Adulte, Hôpital Necker, and Paris V University Service de Néphrologie et Transplantation, Hôpital Saint-Louis, Paris, France.

Transplantation
|November 30, 2005
PubMed
Abstract

Insights

Switching kidney transplant patients from calcineurin inhibitors (CNI) to sirolimus can cause proteinuria. This side effect appears reversible upon sirolimus withdrawal, suggesting careful patient selection is needed.

Area of Science:

  • Nephrology
  • Transplantation Immunology

Background:

  • Calcineurin inhibitors (CNI) are standard immunosuppressants for kidney transplant recipients.
  • Deteriorating renal function in CNI-treated patients prompts consideration of alternative agents like sirolimus.
  • The impact of switching from CNI to sirolimus on proteinuria requires investigation.

Purpose of the Study:

  • To investigate the incidence and reversibility of proteinuria after switching from CNI to sirolimus in kidney transplant recipients.
  • To assess the correlation between pre-existing proteinuria and post-switch renal function decline.

Main Methods:

  • Retrospective analysis of 68 kidney transplant recipients switched from CNI to sirolimus.
  • 24-hour urine collections for proteinuria measurement at baseline and 3, 6, 12, and 24 months post-switch.
  • Analysis of proteinuria changes in patients switched back to CNI and correlation with renal function.

Main Results:

  • Mean proteinuria increased significantly from 0.39 g/day at baseline to 1.44 g/day at 3 months post-switch (P<0.001).
  • Elevated proteinuria persisted at 6, 12, and 24 months.
  • Proteinuria decreased significantly (P<0.05) from 1.95 g/day to 0.9 g/day when sirolimus was withdrawn in 19 patients.
  • Pre-switch proteinuria >0.3 g/day correlated with subsequent renal function decrease.

Conclusions:

  • Kidney transplant recipients on CNI may experience reversible proteinuria when switched to sirolimus.
  • Monitoring proteinuria is crucial after switching to sirolimus.
  • Patients with pre-existing proteinuria may be at higher risk for adverse renal outcomes after the switch.

Related Concept Videos

Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Renal Corpuscle01:20

Renal Corpuscle

The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous capillaries...